Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Morgensztern

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
Journal of Thoracic Disease|June 17, 2024
Factors associated with incomplete resection for large, locally invasive non-small cell lung cancerWhitney S Brandt, Zhizhou Yang, Brendan T Heiden, et al.
Lung Cancer (Amsterdam, Netherlands)|March 29, 2026
Evaluating the safety and efficacy of chemotherapy in patients with relapsed small cell lung cancer combined with allopurinol and MycoPhenolate (CLAMP)Brendan Knapp, Saiama N Waqar, Jeffrey P Ward, et al.
Cancer Chemotherapy and Pharmacology|November 7, 2020
A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumorsHaeseong Park, Kerry Williams, Nikolaos A Trikalinos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2015
Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation TherapyVarun Puri, Traves D Crabtree, Jennifer M Bell, et al.
Clinical Lung Cancer|December 12, 2022
Trends in Stage I Lung CancerAashray Singareddy, Mary Ellen Flanagan, Pamela P Samson, et al.
The Annals of Thoracic Surgery|August 1, 2015
Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?Pamela Samson, Aalok Patel, Traves D Crabtree, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2022
Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumorsNusayba A Bagegni, Haeseong Park, Katlyn Kraft, et al.
British Journal of Cancer|June 25, 2019
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancerDaniel Morgensztern, Michal Rose, Saiama N Waqar, et al.
The Annals of Thoracic Surgery|August 31, 2015
The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness AnalysisPamela Samson, Aalok Patel, Cliff G Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2026
Reply to: Delta-Like Ligand 3 Expression Across Lung Neuroendocrine Subtypes: Interpreting Response in Small Cell Lung Cancer and BeyondMartin Wermke, Valentina Gambardella, Yasutoshi Kuboki, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
Journal of Thoracic Disease|June 17, 2024
Factors associated with incomplete resection for large, locally invasive non-small cell lung cancerWhitney S Brandt, Zhizhou Yang, Brendan T Heiden, et al.
Lung Cancer (Amsterdam, Netherlands)|March 29, 2026
Evaluating the safety and efficacy of chemotherapy in patients with relapsed small cell lung cancer combined with allopurinol and MycoPhenolate (CLAMP)Brendan Knapp, Saiama N Waqar, Jeffrey P Ward, et al.
Cancer Chemotherapy and Pharmacology|November 7, 2020
A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumorsHaeseong Park, Kerry Williams, Nikolaos A Trikalinos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2015
Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation TherapyVarun Puri, Traves D Crabtree, Jennifer M Bell, et al.
Clinical Lung Cancer|December 12, 2022
Trends in Stage I Lung CancerAashray Singareddy, Mary Ellen Flanagan, Pamela P Samson, et al.
The Annals of Thoracic Surgery|August 1, 2015
Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?Pamela Samson, Aalok Patel, Traves D Crabtree, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2022
Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumorsNusayba A Bagegni, Haeseong Park, Katlyn Kraft, et al.
British Journal of Cancer|June 25, 2019
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancerDaniel Morgensztern, Michal Rose, Saiama N Waqar, et al.
The Annals of Thoracic Surgery|August 31, 2015
The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness AnalysisPamela Samson, Aalok Patel, Cliff G Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2026
Reply to: Delta-Like Ligand 3 Expression Across Lung Neuroendocrine Subtypes: Interpreting Response in Small Cell Lung Cancer and BeyondMartin Wermke, Valentina Gambardella, Yasutoshi Kuboki, et al.
Pageof 19